GE HealthCare Technologies Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $GEHC in the last 30 days.
See all $GEHC insider activity →GE HealthCare Technologies (GEHC) introduced three new cardiovascular ultrasound systems: Vivid Explorer, Vivid Advanced, and Vivid Focus. These systems, showcased at the European Society of Cardiology Congress 2026, offer advanced imaging and AI-enabled workflow tools. They have received CE Mark but await U.S. FDA 510(k) clearance. GEHC stock closed at $72.48, up 0.55% in pre-market trading.
GE HealthCare Technologies reported an 11.1% year-over-year increase in organic orders for Q2, with a record backlog of $23.9 billion. Orders grew across all segments, and 85% of Q3 equipment revenue is already secured. The company reaffirmed its full-year revenue growth guidance of 3% to 4%, but execution and inflation remain key challenges.
Candelis and GE HealthCare have partnered to expand access to remote ultrasound breast exams. Candelis' StreamVue will support viewing of images from GE HealthCare's Invenia ABUS systems, offering secure, rapid image access for radiologists. The collaboration aims to improve workflow efficiency and reduce costs for healthcare organizations.
Over the past 7 days, alphai's AI scored 4 news stories mentioning GEHC (GE HealthCare Technologies Inc.). Coverage has skewed bullish: 4 bullish, 0 neutral, and 0 bearish.
Recent GEHC coverage spans technology, corporate actions and earnings.
The product launch may boost revenue growth in the cardiovascular imaging market and support the stock in the short term.
Strong order growth and record backlog suggest upside potential if conversion remains high.
Enhances GE's imaging ecosystem and could increase adoption of Invenia ABUS.
Positive order and backlog data may support short‑term price appreciation.
New CFO from Xylem may influence health‑care finance strategy.
alphai scores every news story that mentions GEHC with an AI model for sentiment and relevance, and aggregates insider trades from GE HealthCare Technologies Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
GE HealthCare Technologies (GEHC) introduced three new cardiovascular ultrasound systems: Vivid Explorer, Vivid Advanced, and Vivid Focus. These systems, showcased at the European Society of Cardiology Congress 2026, offer advanced imaging and AI-enabled workflow tools. They have received CE Mark but await U.S. FDA 510(k) clearance. GEHC stock closed at $72.48, up 0.55% in pre-market trading.
2 min readGE HealthCare Technologies reported an 11.1% year-over-year increase in organic orders for Q2, with a record backlog of $23.9 billion. Orders grew across all segments, and 85% of Q3 equipment revenue is already secured. The company reaffirmed its full-year revenue growth guidance of 3% to 4%, but execution and inflation remain key challenges.
2 min readCandelis and GE HealthCare have partnered to expand access to remote ultrasound breast exams. Candelis' StreamVue will support viewing of images from GE HealthCare's Invenia ABUS systems, offering secure, rapid image access for radiologists. The collaboration aims to improve workflow efficiency and reduce costs for healthcare organizations.
2 min readGE HealthCare (GEHC) reports record backlog and strong order momentum, with Pharmaceutical Diagnostics driving growth. The company projects 7% growth over five years but faces inflation and tariff risks. GEHC shares are down 9.2% YTD, outperforming the industry but lagging the S&P 500. The company has a market cap of $33.8 billion and a Zacks Rank #2 (Buy).
3 min readCFO turnover at Fortune 500 and S&P 500 companies is projected to reach 18.3% in 2026, the highest since 2020. Key CFO changes include AT&T, Caterpillar, Oracle, Nike, and Pfizer. The average age of new CFOs is projected to be 48, down from 52 in 2025. Notable appointments include GE HealthCare, Baxter International, and Ameresco.
5 min readCentene's CFO Drew Asher to step down by year-end, succeeded by Chris Neczypor. Baxter International names John Rogers as CFO. GE HealthCare appoints William K. Grogan as CFO. QVC Group's CEO David Rawlinson steps down, Mike George takes interim role. Changes impact leadership at Fortune 500 companies.
3 min readGE HealthCare Technologies (GEHC) said it will appoint William Grogan as CFO effective Sept. 14, 2026. He will replace Jay Saccaro, who stepped down for a role outside the medical technology industry. Interim CFO George Newcomb will remain Controller and Chief Accounting Officer. GEHC was trading at $73.31, up 1.29% on Nasdaq.
2 min readGE HealthCare Technologies Inc. (GEHC) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99 GE HealthCare appoints William Grogan as Chief Financial Officer CHICAGO — August 18, 2026 — GE HealthCare (Nasdaq: GEHC), a leading global precision care innovator, today announced the appointment of William (Bill) Grogan as Chief Financial Officer, effective Septembe
2 min readGE HealthCare said CFO Jay Saccaro will leave Aug. 14 to become Zoetis’ newly created EVP, CFO and COO on Aug. 17, overseeing global finance plus manufacturing and supply. GE HealthCare named George Newcomb interim CFO. The company reported Q2 revenue of $5.3B, up 5.7%, organic growth 3.5%, orders up 11.1%, backlog $23.9B, and reaffirmed 2026 guidance.
4 min readGE HealthCare Technologies (GEHC) launched new ultrasound systems, including LOGIQ e laptop units and an expanded breast imaging platform with AI tools, portability, and regulatory clearances. The stock rose 16.8% over 30 days to $73.69 and 19.8% over 90 days. A fair-value narrative sets $81.72, citing future imaging and AI product pipeline, while noting tariff and China regulatory risks.
4 min read
